Aging |
Aging & Elderly Health; Aging Health; Aging/elderly; Elderly |
Clinical Trial: The Difference in Presentation Level of Variant Receptors in Female Breast Tissue in Macromastia and Micromastia
This study is not yet open for patient recruitment.
Verified by National Taiwan University Hospital June 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Aging | Procedure: obtain surgical specimen for analysis | Phase I |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Educational/Counseling/Training, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Expected Total Enrollment: 60
Study start: January 2006; Expected completion: December 2006
Last follow-up: August 2006; Data entry closure: September 2006
Large breasts cause neck and back pain, irritating grooves, cut in the skin of the shoulders by the pressure of brassiere straps, breast pain, and maceration and dermatoses in the inframammary region. From a psychological point of view, excessively large breasts can be troublesome focus of embarrassment for the teenager as well as the woman in her senior years. Unilateral hypertrophy with asymmetry heightens embarrassment. Thus, patients seek to reduce the size of their breasts.
In the human female, variant receptors were detected in epithelial cells in normal breast tissue, benign breast lesions, breast carcinoma tissue, and breast cancer cell lines2-11. The cause of the difference in breast development status is still unclear. Abnormalities at the tissue receptor level may be important in the pathophysiology of macromastia. This study aimed to make clear the difference in variant receptor levels between breast hypertrophy patients and macromastia ones by examining the receptor levels in breast tissue. Then, we could explore the possible etiology of mammary hypertrophy and macromastia.
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- patients receiving reduction mammoplasty
Exclusion Criteria:
-
Location and Contact Information
Hao-Chih Tai, M.D., Principal Investigator, National Taiwan University Hospital
More Information
Last Updated: September 14, 2005
Record first received: September 12, 2005
ClinicalTrials.gov Identifier: NCT00173251
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-20

Not Signed In -

